Gross Margin
12.28%vs Specialty Chemicals peers Updated Nov 19, 2026Profit Margin
-6.76%vs Specialty Chemicals peers Updated Nov 19, 2026Operating Margin
-4.50%vs Specialty Chemicals peers Updated Nov 19, 2026Return on Assets (TTM)
-1.46%vs Specialty Chemicals peers Updated Nov 19, 2026Return on Equity (TTM)
-7.07%vs Specialty Chemicals peers Updated Nov 19, 2026Revenue (TTM)
5.40BCNY809.93M · vs all stocks (USD) Updated Nov 19, 2026Revenue per Share (TTM)
5.71CNYUpdated Nov 19, 2026Quarterly Revenue Growth
-7.50%vs Specialty Chemicals peers Updated Nov 19, 2026Gross Profit (TTM)
707.84MCNY106.17M · vs all stocks (USD) Updated Nov 19, 2026EBITDA (TTM)
293.89MCNY44.08M · vs all stocks (USD) Updated Nov 19, 2026Net Income (TTM)
-365.07MCNY-54.76M · vs all stocks (USD) Updated Nov 19, 2026Quarterly Earnings Growth (YoY)
38.52%vs Specialty Chemicals peers Updated Nov 19, 2026Operating Cash Flow (TTM)
76.89MCNY11.53M · vs all stocks (USD) Updated Nov 19, 2026Levered Free Cash Flow (TTM)
152.51MCNY22.87M · vs all stocks (USD) Updated Nov 19, 20265-Year Average Dividend Yield
0.37%Updated Nov 19, 2026Payout Ratio
24.37%vs Specialty Chemicals peers Updated Nov 19, 2026Minority Interest (Equity)
680.04MCNYFY2025 · Dec 31, 2025Revenue
5.55BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
4.74BCNYFY2025 · Dec 31, 2025Gross Profit
814.42MCNYFY2025 · Dec 31, 2025Operating Income
-100.34MCNY-15.05M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
-288.40MCNYFY2025 · Dec 31, 2025Income Tax Expense
15.33MCNYFY2025 · Dec 31, 2025Net Income
-303.73MCNYFY2025 · Dec 31, 2025EBIT
-209.74MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
293.89MCNYFY2025 · Dec 31, 2025Research & Development
198.01MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
189.55MCNYFY2025 · Dec 31, 2025Other Operating Expenses
32.63MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
33.92MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
78.67MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.3037CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.3037CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
945.32MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
945.32MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-303.73MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
16.64MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-5.79MCNYFY2025 · Dec 31, 2025Free Cash Flow
-342.20MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.05BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-303.73MCNYFY2025 · Dec 31, 2025Other Non-cash Items
129.74MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
237.65MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-69.45MCNYFY2025 · Dec 31, 2025Capital Expenditures
-336.41MCNYFY2025 · Dec 31, 2025Net Acquisitions
14.00CNYFY2025 · Dec 31, 2025Sale of Investments
1.90MCNYFY2025 · Dec 31, 2025Other Investing Activity
-428.44MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-762.94MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
3.03BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-3.12BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-70.45MCNYFY2025 · Dec 31, 2025Other Financing Charges
406.69MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
243.51MCNYFY2025 · Dec 31, 2025